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Abstract 
Objectives: To determine the willingness and barriers of community pharmacists to provide pain management and depression MTM 
services. 
Methods: An anonymous, self-administered survey was distributed electronically to 350 licensed pharmacists in a supermarket 
pharmacy chain.  The survey consisted of a 40 question, Likert-type scale, where strongly disagree was assigned a value of one and 
strongly agree a value of seven.  Constructs measured included: MTM interest, comfort with MTM, confidence with appropriate 
medication use and adjustment, educational needs, training required, time constraints, and work-related factors.  Demographic data 
was also collected.  
Results: A total of 186 (53%) community pharmacists completed the survey.  These pharmacists worked in an environment where 
MTM was currently being provided.  Ninety percent of respondents averaged 0-5 MTM sessions per 4 week period.  Pharmacists 
agreed that patients would benefit from MTM focused on pain (median 6 IR[5-7]) and/or depression (median 6 IR[5-7]) and agreed 
pharmacists can have positive interventions in these situations (pain: median 6 IR[5-7]; depression: median 6 IR[5-7]).    Pharmacists 
surveyed were interested in continuing education and live presentation as preferred methods to improve knowledge of pain 
management and depression. 
Conclusion: Pharmacists are interested in and believe patients would benefit from MTM specifically for pain management and 
depression.  Barriers to MTM focused on pain and depression were pharmacist training and workflow issues with the MTM process.   
 
 
Introduction 
With one in ten Americans now taking an antidepressant 
medication, there is greater need for pharmacist’s 
interventions.1 MTM is defined as a distinct service or group 
of services that optimize therapeutic outcomes for individual 
patients [that] are independent of, but can occur in  
conjunction with, the provision of drug product.2 Currently,  
pharmacists provide MTM in a variety of settings such as 
physician offices and community pharmacies.  These sessions 
can be both comprehensive as well as focused on a specific  
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condition.  Regardless, pharmacists that provide these 
services need to feel confident and adequately trained on 
many different disease states and medications to provide  
true comprehensive medication management.  It is important 
to note that other literature has assessed general MTM 
barriers, but little information is available on specific disease 
state service implementation aspects.  
 
In addition to depression management becoming a key 
disease state for pharmacist interventions, pain management 
initiatives have left a key role for pharmacists.  A pilot 
initiative is currently underway in the state of Ohio with the 
Bureau of Workers Compensation (BWC) and several 
pharmacies to provide MTM services focused on pain.  If this 
pilot is successful and similar programs expand statewide or 
nationwide, it may be helpful for community pharmacists and 
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practice leaders to understand the readiness of their 
pharmacists, as well as how to best train their pharmacists 
who need additional support. In regards to depression, 
compliance is key for success and pharmacists can play a 
crucial role in counseling patients on treatment expectations 
and importance of therapy.3 
 
Few studies have assessed the pharmacists’ role in MTM 
specifically involving pain management and depression.  The 
objective of this study is to determine the willingness and 
barriers of community pharmacists to provide pain and 
depression MTM services. 
Methods 
 
This particular supermarket pharmacy chain consists of 121 
stores across central, northwest, and southeast Ohio and 350 
licensed pharmacists who currently provide MTM through 
platforms such as Outcomes, Mirixa, and the pharmacy’s 
own clinical platform.  Outcomes® and Mirixa® are two of 
several platforms in existence but are ones that are most 
familiar to the surveyed pharmacists.  Both of these platforms 
allow for billing and the management of electronic health 
records.  
 
An anonymous, self-administered, electronic survey 
containing 60 questions was distributed to all 350 licensed 
pharmacists in a supermarket pharmacy chain who received 
basic MTM training.  To distribute the survey, each 
pharmacist received an email containing the link to the 
survey using the Qualtrics system.  Respondents were 
asked to complete the survey within two weeks of the survey 
announcement.  A reminder email containing the survey link 
was distributed three times – at one week before the survey 
closed, at one day before close, and one to extend the 
deadline for 3 days (over a weekend) to increase the survey 
response rate. As the purpose of the survey was to assess 
existing willingness and barriers to providing pain and 
depression MTM services, a control group was not selected, 
and no additional intervention took place. 
 
Survey respondents were asked to rate each statement using 
a Likert-type scale, where strongly disagree was assigned a 
value of one, moderately disagree a value of two, slightly 
disagree a value of three, neither disagree or agree a value of 
four, slightly agree a value of five, moderately agree a value 
of six, and strongly agree a value of seven (Table 2).  Related 
literature on MTM barriers was reviewed during survey 
development.4,5  Thirteen questions were asked regarding 
MTM interest and comfort with MTM, seven questions were 
asked regarding confidence with appropriate medication use 
and adjustment, six questions were asked regarding 
educational needs and training requirements, and eight 
questions focused on time constraints and work-related 
factors.  At the end of the survey, five questions collected 
demographic information such as age, gender, years in 
practice, degree obtained, prescription volume, and average 
number of MTMs per period. The remainder of the questions 
were geared towards workflow and job setting issues.  To 
assess survey validity, 10 pharmacists, from a super market 
pharmacy chain and/or Ohio Northern University, piloted the 
survey, and changes were made prior to survey release.  To 
analyze survey data, SPSS version 15.0 (SPSS, Chicago) was 
used.  Descriptive statistics and Kruskal-Wallis were used.  
Alpha was set a-priori at p=0.05. The Ohio Northern 
University institutional review board approved this survey.  
 
Results 
 The survey was emailed to all 350 pharmacists of a 
supermarket pharmacy chain and 186 pharmacists completed 
the survey (53.1% response rate). Table 1 lists demographic 
data for survey participants. Pharmacists slightly to 
moderately agreed that they were interested in providing 
MTM specifically for pain (median 5 IR[4-6]) and 
depression(median 6 IR[4-6]).  Respondents moderately 
agreed their patients would benefit from MTM focused on 
pain (median 6 IR[5-7]) and depression (median 6 IR[5-7]) as 
well as believed a pharmacist can have positive interventions 
in pain (median 6 IR[5-7]) and depression (median 6 IR[5-7])).  
Those surveyed were neutral to slightly agree regarding their 
knowledge in using patient assessment tools for pain (i.e., 
numerical ranking, FACES pain rating scale, etc.) (median 5 
IR[3-6]) and for depression (i.e., PHQ-9) (median 4 IR[3-5]).  In 
regards to patients diagnosed with depression who also 
suffer from co-morbid anxiety, pharmacists slightly agreed on 
whether they felt confident counseling those patients 
(median 5 IR[3-6]).  Pharmacists slightly agreed in regards to 
confidence counseling patients on the metabolic side effects 
of medications used in mental health conditions (median 5 
IR[4-6]).  
 
Pharmacists surveyed were more confident to provide MTM 
for diabetes (median 6 IR[6-7]) compared to pain (median 5 
IR[4-6]) and depression (median 5 IR[4-6]) management.  
Respondents indicated that they were more adequately 
trained to provide MTM focused on diabetes (median 6 IR[5-
7]) compared to pain (median 5 IR[3-6]) and depression 
(median 5 IR[3-6]). 
 
Respondents moderately agreed that their job satisfaction 
would increase if they conducted more MTM sessions 
(median 6 IR[4-6]).  When asked “with all of my other 
responsibilities, MTM is too much extra work for me,” 
pharmacists slightly agreed (median 5 IR[3-6]).  Respondents 
were undecided when asked if they feel their current MTM 
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load is too much (median 4 IR[3-5]).  Pharmacists also 
remained undecided when asked if physicians in their area 
were open to pharmacists providing MTM services (median 4 
IR[3-5]).  Pharmacists slightly agreed when asked if they were 
comfortable recruiting patients for MTM by calling patients 
from a list (“cold calling”) (median 5 IR[3-6]) as well as if they 
felt they were effective (median 5 IR[3-6]).  
 
Pharmacists slightly disagreed with the statement they were 
able to provide MTM because Kroger provided adequate 
technician help (median 3 IR[2-5])and moderately disagreed 
that technicians assisted with MTM (i.e., set up 
appointments, submitting claims, etc.) (median 2 IR[1-3]).  
Respondents also slightly disagreed that they were able to 
provide MTM because Kroger provided sufficient pharmacist 
overlap (median 3 IR[2-5]).  Pharmacists that completed the 
survey also were undecided when asked if they were willing 
to provide MTM because Kroger provided incentives (median 
4 IR[4-6])and slightly agreed that they enjoyed providing 
MTM through Kroger’s existing model (i.e., Mirixa, 
Outcomes) (median 5 IR[4-6]). 
 
Pharmacists strongly agreed they would benefit from 
additional training regarding pain (median 7 IR[6-7]) and 
depression (median 7 IR[6-7]) management MTM.  In regards 
to additional training, respondents were given a list of the 
following items and asked to rank the forms of additional 
training based on what they most prefer: Continuing 
Education (CE), Review Article, Live Presentation, Web 
Presentation, and Kroger Television (KTV, an internal 
television network used for training and associate 
communications).  Continuing Education (CE) was ranked as 
most preferred form of additional training followed by live 
presentation, web presentation, review article, and KTV.  
When asked to rank the given disease states in order of their 
comfort level, pharmacists felt most comfortable with 
hypertension (37.6% of respondents ranking as most 
preferred) followed by diabetes, dyslipidemia, pain, and 
depression.  
 
Additionally, statistically significant differences were 
observed when respondents with a BSPharm degree were 
compared to those with a PharmD degree.  Compared to 
pharmacists with a BSPharm degree, pharmacists with a 
PharmD degree responded more positively to several 
statements (Table 2).  
Discussion 
 
In 2009, a similar study was performed assessing pharmacists’ 
perceptions regarding implementation of medication therapy 
management reported that pharmacists had a desire for 
additional disease state training.5  Many pharmacists within 
this supermarket pharmacy chain receive diabetes-specific 
coaching and training, which may be one reason for the level 
of comfort with diabetes-related issues.  Interestingly, 
pharmacists did not report feeling strongly confident and/or 
adequately trained to provide MTM for pain management or 
depression, but did report feeling strongly confident and/or 
adequately trained to provide MTM for diabetes. Current 
literature indicates there is a link between diabetes and 
depression, thus impacting a diabetic’s quality of life.6  It may 
be important to identify these areas of weakness and 
continue to build upon them to strengthen the application of 
the MTM encounter.  Also, the accessibility of community 
pharmacists puts them in a prime position for these types of 
interventions as most pharmacists are available after hours 
and on weekends. 
 
Several differences were found between those pharmacists 
with a BSPharm degree compared to those with a PharmD 
degree.  Interestingly pharmacists with a PharmD degree 
agreed more strongly with statements related to knowledge 
with patient assessment tools and adequate training to 
provide MTM for diabetes.  Knowledge of differences in 
pharmacists based on their training may help employers and 
leaders to understand what additional training may be helpful 
to different populations of pharmacists.  
 
Some pharmacists seemed concerned that the dispensing 
volume may impact the ability to offer MTM.  Busier stores 
(those filling an average of >1500 per week) answered 
similarly to slower stores (those filling an average of <1500 
per week).  Although pharmacies with different dispensing 
volumes may have different challenges when incorporating 
MTM into the practice workflow, it does not appear that 
dispensing volume may be a major determinant as to the 
feasibility of incorporation of MTM.  
 
The strengths of this survey are that the survey participants 
are involved with MTM at their current practice site, 83% of 
pharmacists in this supermarket pharmacy chain have 
conducted at least one MTM encounter in the past year.  A 
potential limitation of this study is that only pharmacists in a 
certain area were included and this supermarket pharmacy 
chain may have more emphasis on MTM than other 
pharmacies.  Pharmacists in other regions may have different 
experience or opinions towards pain and mental health MTM, 
and may have different scopes of practices based on state 
law that may be more or less supportive of MTM and direct 
patient care.  The response rate of 53% is also a limitation of 
this study as it could be higher, but was still thought to 
provide useful information for follow-up and planning.  Also, 
despite efforts to communicate that answers were 
confidential, some pharmacists may have felt concern about 
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possible repercussions of their responses, and may not have 
answered truthfully.  A limitation regarding the survey design 
was that when asked about average number of MTM sessions 
the pharmacists completed per period, those who completed 
zero MTM were lumped in the same category as those who 
completed 1-5 MTM sessions. However, MTM is an 
expectation of all pharmacists in this corporate division and 
during the last calendar year, approximately 300 pharmacists 
participated in MTM. Thus, the authors felt it was reasonable 
to have a category devoted to minimal MTM experience.  
 
As more and more pharmacies are looking to incorporate 
both general and targeted MTM into their workflow, it can be 
important for those in leadership to understand the major 
barriers (i.e., workflow and education), and may find it 
interesting to specifically note that pharmacists showed slight 
agreement with the statement that job satisfaction may 
improve if they conducted more MTM sessions. Along those 
same lines, those in leadership may find it valuable to know 
that on average, pharmacists moderately agreed that they 
would benefit from additional training regarding pain and 
depression management MTM, and that CE was the preferred 
route. This may empower pharmacist to reach out to their 
colleagues to develop strategies for reviewing disease states 
where pharmacists feel less comfortable.  
 
Conclusion 
Pharmacists are interested in and believe patients would 
benefit from MTM specifically for pain management and 
depression.  Barriers to MTM focused on pain and depression 
were pharmacist training and work flow issues with the MTM 
process.  There are opportunities to overcome these barriers 
with continuing education and live presentations, and 
incorporating technicians into the work flow as technicians 
can play a key role in the MTM process.  Further research on 
how best to prepare pharmacists for a wide variety of direct 
patient care opportunities should be conducted.  
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TABLE 1 – Demographics (N=186) 
Parameter Number (%) 
Sex 
M 77 (41) 
F 109 (59) 
Education* 
 
BSPharm 113 (61) 
PharmD 79 (42) 
Residency 6 (3) 
Age 
20-29 42 (23) 
30-39 68 (37) 
40-49 43 (23) 
50-59 21 (11) 
Older than 60 12 (6) 
Average 
weekly 
prescription 
volume 
<1500 55 (30) 
Strongly 
Disagree 
1 
>1500 131 (70) 
*Participants were asked to select all that apply 
 
 
 
 
 
TABLE 2 – Pharmacist Perceptions 
Scale: 
Strongly 
Disagree 
1 
Moderately 
Disagree 
2 
Slightly 
Disagree 
3 
Neither 
Disagree or 
Agree 
4 
Slightly  
Agree 
5 
Moderately 
Agree 
6 
Strongly  
Agree 
7 
 
 PharmD (median) 
BSPharm 
(median) 
Kruskal-
Wallis  
p-value 
I am knowledgeable using patient assessment tools for  pain 5 4 .005 
I am knowledgeable using patient assessment tools for depression 5 3 .009 
I am adequately trained to provide MTM for diabetes 7 5 .000 
My job satisfaction will increase if I conduct more MTM sessions 6 5 .023 
I enjoy providing MTM through Kroger’s existing model (i.e., Mirixa, Outcomes) 6 5 .021 
All of the following listed items were found to be statistically significant (p < 0.05) 
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